These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21789170)

  • 1. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
    Putluri N; Shojaie A; Vasu VT; Nalluri S; Vareed SK; Putluri V; Vivekanandan-Giri A; Byun J; Pennathur S; Sana TR; Fischer SM; Palapattu GS; Creighton CJ; Michailidis G; Sreekumar A
    PLoS One; 2011; 6(7):e21417. PubMed ID: 21789170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
    Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
    Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.
    Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
    Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
    Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
    Saraon P; Musrap N; Cretu D; Karagiannis GS; Batruch I; Smith C; Drabovich AP; Trudel D; van der Kwast T; Morrissey C; Jarvi KA; Diamandis EP
    J Biol Chem; 2012 Oct; 287(41):34019-31. PubMed ID: 22908226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
    Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
    Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic effects of androgen deprivation therapy treatment for prostate cancer.
    Chi JT; Lin PH; Tolstikov V; Oyekunle T; Chen EY; Bussberg V; Greenwood B; Sarangarajan R; Narain NR; Kiebish MA; Freedland SJ
    Cancer Med; 2020 Jun; 9(11):3691-3702. PubMed ID: 32232974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.
    Vellaichamy A; Dezso Z; JeBailey L; Chinnaiyan AM; Sreekumar A; Nesvizhskii AI; Omenn GS; Bugrim A
    PLoS One; 2010 Jun; 5(6):e10936. PubMed ID: 20532174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A
    Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
    Raclaw KA; Heemers HV; Kidd EM; Dehm SM; Tindall DJ
    Prostate; 2008 Nov; 68(15):1696-706. PubMed ID: 18726983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
    Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
    Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
    Montgomery RB; Mostaghel EA; Vessella R; Hess DL; Kalhorn TF; Higano CS; True LD; Nelson PS
    Cancer Res; 2008 Jun; 68(11):4447-54. PubMed ID: 18519708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
    Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
    J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.
    Kaushik AK; Vareed SK; Basu S; Putluri V; Putluri N; Panzitt K; Brennan CA; Chinnaiyan AM; Vergara IA; Erho N; Weigel NL; Mitsiades N; Shojaie A; Palapattu G; Michailidis G; Sreekumar A
    J Proteome Res; 2014 Feb; 13(2):1088-100. PubMed ID: 24359151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor involvement in the progression of prostate cancer.
    Suzuki H; Ueda T; Ichikawa T; Ito H
    Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.
    Höti N; Shah P; Hu Y; Yang S; Zhang H
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 28116790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
    Chatterjee B
    Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.